ARC logo.png
Over-the-Counter (OTC) Drugs Market Value Forecasted To Reach US$ 208.9 Billion By 2027: Acumen Research and Consulting
March 31, 2021 11:15 ET | Acumen Research and Consulting
LOS ANGELES, March 31, 2021 (GLOBE NEWSWIRE) -- The Global Over-the-Counter (OTC) Drugs Market is expected to grow at a CAGR of around 5.2% from 2020 to 2027 and reach the market value of over US$...
AMR Logo.png
Topical Pain Relief Market Size to Reach $12.21 Billion, Globally, by 2027 at 5.2% CAGR: Allied Market Research
March 25, 2021 08:50 ET | Allied Market Research
Portland, OR, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream,...
Logo.jpg
ProPhase Announces Change in Tax Treatment of 2018 Dividends
April 09, 2019 16:57 ET | ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, April 09, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) announced a change in the reporting of dividends paid to its stockholders in...
Logo.jpg
PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND
December 26, 2018 09:15 ET | ProPhase Labs, Inc.
DOYLESTOWN, PA, Dec. 26, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of...
Logo.jpg
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2018
November 14, 2018 07:30 ET | ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 14, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported its financial results for the three and nine months ended...
IMC Logo.jpg
Travelan® Revenue Grows Significantly in US and Australia
February 16, 2018 09:30 ET | Immuron Limited
Key Highlights: Immuron’s flagship product Travelan® reports revenue in excess of AUS$914K for first 6mths of FY2018  Travelan® US experienced a 250% increase in sales year over year reaching...
NewMarket Technology, Inc. Publishes Business Plan 101 With Candid Investment Potential Perspective as Company Enters 4th Qtr. With Plans to Post Record Results
October 02, 2009 09:55 ET | NewMarket Technology, Inc.
DALLAS, TX--(Marketwire - October 2, 2009) - NewMarket Technology, Inc. (PINKSHEETS: NWMT) today released a letter to shareholders from CEO Philip Verges. NewMarket is a fully reporting company...
Statement From the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations on Over-the-Counter Medicines Containing Acetaminophen
June 30, 2009 19:00 ET | Consumer Healthcare Products Association
WASHINGTON, DC--(Marketwire - June 30, 2009) - Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the recommendations...